Many epilepsy patients cannot live the lives they want because of the unpredictability of seizures. The founders of Nile AI believe that doesn’t have to be the case. Spun-off from UCB, a leader in the development of epilepsy drugs, Nile AI is developing a systematic solution in a platform that unites all epilepsy stakeholders in the goal of rapidly getting each patient into the therapy that works best for them
In many areas of medicine, despite the availability of excellent drug or device therapies, patients don't experience the best possible outcomes because of systemic problems in care delivery. Increasingly, therapy developers are wrapping their arms around this healthcare problem with digital health and health IT solutions. Orthopedic companies were probably the first to adopt this strategy, with digital health collaborations that reach joint reconstruction patients in the period following surgery, to make sure they comply with the rehab that fosters good outcomes. In neurology, Medtronic plc was early in taking on some of the delivery gaps in time-sensitive ischemic stroke, with its Stroke Care Solution, one element of which is a partnership with the artificial intelligence company Viz.Ai, which offers a hospital triage technology to get stroke patients into the proper treatment ASAP. Cardiology companies, too, are thus broadening their focus. In late February, Terumo Corp. acquired Health Outcomes Sciences, a predictive analytics company providing patient-specific insights at the point of care.